'Pro version' of cisplatin keeps its cancer-killing power while reducing side effects
Researchers have developed 'cisproplatin,' a new molecule that combines the chemotherapy drug cisplatin with probenecid to reduce severe side effects. This 'pro version' remains stable in the body and only activates under tumor-like conditions, potentially protecting healthy organs.
Why it matters
Improving the delivery of chemotherapy could significantly enhance the quality of life for cancer patients by reducing debilitating nerve and kidney damage.
edited by Lisa Lock , reviewed by Robert Egan
This article has been reviewed according to Science X's editorial process and policies . Editors have highlighted the following attributes while ensuring the content's credibility:
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in